U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
168691168691WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated VasculitidesActive, not recruitingNo Results AvailableSystemic Wegener's GranulomatosisDrug: Azathioprine: 2 mg/kg/day|Drug: methotrexate 0.3 mg/kg/week, to a maximum and optimal dose of 25 mg/weekhttps://ClinicalTrials.gov/show/NCT00349674
168692168692Influence Of Omeprazole On The Anti-Platelet Action Of ClopidogrelCompletedNo Results AvailableCoronary Heart DiseaseDrug: impact on VASP testhttps://ClinicalTrials.gov/show/NCT00349661
168693168693Conservative or Operative Treatment for the Shoulder Impingement Syndrome?Active, not recruitingNo Results AvailableShoulder Impingement SyndromeProcedure: acromioplastyhttps://ClinicalTrials.gov/show/NCT00349648
168694168694A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.CompletedNo Results AvailableObesityDrug: Metformin and Metformin + Fenofibratehttps://ClinicalTrials.gov/show/NCT00349635
168695168695Clinical Trial Ceftriaxone in Subjects With ALSCompletedHas ResultsAmyotrophic Lateral Sclerosis|ALSDrug: ceftriaxone|Other: placebohttps://ClinicalTrials.gov/show/NCT00349622
168696168696A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)CompletedNo Results AvailableAcute Lymphocytic LeukemiaDrug: Decitabinehttps://ClinicalTrials.gov/show/NCT00349596
168697168697Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL ImplantationCompletedNo Results AvailableCataract|Dry EyeDrug: Topical Cyclosporine, Tearshttps://ClinicalTrials.gov/show/NCT00349583
168698168698Xtractâ„¢ Aspiration Catheter Registry StudyCompletedNo Results AvailableFresh Soft Emboli or Thrombi in the Arteries.Device: Xtract Aspiration Catheterhttps://ClinicalTrials.gov/show/NCT00349570
168699168699Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate CancerCompletedNo Results AvailableProstate CancerDrug: bevacizumab, bicalutamide and goserelin|Procedure: intensity modulated radiation therapy (IMRT)https://ClinicalTrials.gov/show/NCT00349557
168700168700Validation of the Spanish Version of the Neck Disability IndexCompletedNo Results AvailableNeck Pain|Cervicalgiahttps://ClinicalTrials.gov/show/NCT00349544
168701168701A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLSCompletedNo Results AvailableRestless Legs SyndromeDrug: Pramipexolehttps://ClinicalTrials.gov/show/NCT00349531
168702168702Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALLWithdrawnNo Results AvailableChronic Myeloid Leukemia|Acute Lymphoblastic LeukemiaDrug: Dasatinibhttps://ClinicalTrials.gov/show/NCT00349518
168703168703Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian CarcinomaRecruitingNo Results AvailableEpithelial Ovarian Carcinoma|Figo Stage IIICProcedure: hyper thermic chemo + surgeryhttps://ClinicalTrials.gov/show/NCT00349505
168704168704A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung CancerCompletedNo Results AvailableSmall Cell Lung CancerDrug: IPhttps://ClinicalTrials.gov/show/NCT00349492
168705168705Increasing Stroke Treatment Through Interventional Change Tactics StudyCompletedNo Results AvailableStrokeBehavioral: Barrier assessment / interactive educational interventionhttps://ClinicalTrials.gov/show/NCT00349479
168706168706Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis SiccaCompletedHas ResultsKeratoconjunctivitis SiccaDrug: CF101|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00349466
168707168707Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent PatientsCompletedNo Results AvailableHemochromatosisDrug: Deferiprone (L1)|Drug: Deferiprone (L1)|Drug: Desferrioxaminehttps://ClinicalTrials.gov/show/NCT00349453
168708168708Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive KeratectomyCompletedNo Results AvailableDry Eye SyndromesDrug: Cyclosporine, Refresh Plushttps://ClinicalTrials.gov/show/NCT00349440
168709168709A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus PatientsCompletedNo Results AvailableType 2 Diabetes Mellitus|Diabetes Mellitus, Type 2Drug: Rosiglitazone 4 mghttps://ClinicalTrials.gov/show/NCT00349427
168710168710Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage GlaucomaRecruitingNo Results AvailableAdvanced Glaucoma|Refractory GlaucomaProcedure: Micropulse Transscleral Cyclophotocoagulation|Procedure: Conventional Transscleral Cyclophotocoagulationhttps://ClinicalTrials.gov/show/NCT00349414
168711168711Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose EscalationWithdrawnNo Results AvailablePainDrug: ketorolac|Drug: morphinehttps://ClinicalTrials.gov/show/NCT00349401
168712168712Safety and Compliance of Taking Mesalamine Once a Day in Pediatric PatientsTerminatedHas ResultsUlcerative ColitisDrug: Asacolhttps://ClinicalTrials.gov/show/NCT00349388
168713168713Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNo Results AvailableHyperlipidemiaDrug: Fenofibrate/Simvastatin|Drug: Fenofibrate/Simvastatin|Drug: Simvastatinhttps://ClinicalTrials.gov/show/NCT00349375
168714168714Testosterone for Men With Insulin Treated Type 2 DiabetesCompletedNo Results AvailableHypogonadism|DiabetesDrug: Testosterone|Drug: 0.9% salinehttps://ClinicalTrials.gov/show/NCT00349362
168715168715HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and AlemtuzumabCompletedHas ResultsLeukaemia, Lymphocytic, ChronicDrug: ofatumumabhttps://ClinicalTrials.gov/show/NCT00349349
168716168716A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.CompletedHas ResultsColorectal CancerDrug: bevacizumab [Avastin]|Drug: XELOX|Drug: bevacizumab [Avastin]|Drug: FOLFOX-4https://ClinicalTrials.gov/show/NCT00349336
168717168717Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in ZambiaCompletedNo Results AvailableSoil-Transmitted Helminth Infection|GrowthBehavioral: Community directed treatmenthttps://ClinicalTrials.gov/show/NCT00349323
168718168718Profile of Depressive Symptoms in Parkinsons DiseaseCompletedNo Results AvailableParkinson Disease|DepressionDrug: Pramipexolehttps://ClinicalTrials.gov/show/NCT00349310
168719168719The Microbiological Spectrum in Acute DacryocystitisCompletedNo Results AvailableDacryocystitishttps://ClinicalTrials.gov/show/NCT00349297
168720168720A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic SyndromeCompletedNo Results AvailableHyperlipidemia CombinedDrug: Combination of 145 mg fenofibrate and 10 mg ezetimibehttps://ClinicalTrials.gov/show/NCT00349284

* Görseller ve İçerik tekif hakkına sahip olabilir